Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.
about
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptorEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabImmunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent CancersInhibition of cell proliferation by an anti-EGFR aptamerDisplayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapyCurrent approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patientsSystems analysis of EGF receptor signaling dynamics with microwestern arrays.Monoclonal antibodies: versatile platforms for cancer immunotherapy.Targeting the EGFR signaling pathway in cancer therapy.Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma.Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma modelEpidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cellsSignaling multiplex of the epidermal growth factor receptor.Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.Consumption of EGF by A431 cells: evidence for receptor recyclingOleanolic acid induces migration in Mv1Lu and MDA-MB-231 epithelial cells involving EGF receptor and MAP kinases activation.Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.Role of ErbB Receptors in Cancer Cell Migration and InvasionPositron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.Recent developments in colorectal cancer treatment by monoclonal antibodies.Improved biochemical strategies for targeted delivery of taxoidsAnti-EGF receptor monoclonal antibodies: biological studies and potential clinical applicationsA HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.Antibody Therapeutics in Oncology.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.Emerging drugs for targeted therapy of bladder cancer.Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
P2860
Q24314620-B1A7B7A5-94C0-4F73-BAA3-A9A976FD74DFQ24652337-B710BF52-19D7-4D93-8FE4-1D9BAD1B3526Q26751473-AEADE0DD-53B9-48D6-B222-027FBAF469F3Q28743866-24BCB94E-6591-4C21-8C0C-B4655E295265Q33358967-6891FA1D-F727-4808-95C6-81B07C7E4E4BQ33576327-B6275F49-5503-40DE-ACAB-3C4ADD3F46CFQ33802940-4BE67359-1BB3-46A7-97FF-893A0CB28077Q33861210-8E60CA7B-4132-48A0-967D-BB9C5F1150DDQ33896605-45BA4CAA-4F31-4266-933E-ED64BC46D986Q34111693-1B2F3E46-801C-4566-8B25-D3A30CFCBFC2Q34246558-15453A21-0E4C-4AEE-A200-F529136D9197Q34263559-4C71AAD4-276D-4FAE-BCF4-F6D260F0D36FQ34294881-3BFB6681-4920-48BD-A74D-E0F5EFF9D6EDQ34451934-1B901160-0046-480E-96E0-EE930FE17BB9Q34618994-3A2A38F1-EFFD-4B0C-9706-16519E180BA4Q35001415-619CCD90-166F-4DFA-8AE1-556B65A7C5C4Q35654360-9261C1CB-744A-4664-B2EC-C7CD54F44C2FQ35825299-1873CF1C-BC94-4C7C-83CD-55D1F84CF19BQ35952148-55A1377E-1EFE-44B8-B4C6-3E5AFC6A5404Q35973340-F4B6E561-AF63-4689-856B-8537B82381A9Q35987785-D494761E-9ED0-4A38-974F-79DD427ABD6DQ36108119-F984E3B5-BEA8-43B0-A843-FF18FBE49A3EQ36232210-B8083ACD-08ED-448D-AD74-496C1B692F4DQ36288371-8BDAD79E-8F24-44CF-B9F1-8E7BB0CB899EQ36293949-2C8F7E5A-841F-46F6-BE2D-92F024404381Q36296101-6CB468A0-D00F-46D5-B598-E20E8FD0E935Q36311027-79A44DD7-B533-4E1D-9CB4-DC7542B3C8FDQ36557471-D4EA2237-CF16-4855-BCF4-BBF290D9355AQ36592213-32E1BF16-0E94-448E-A8DF-060863CC56F8Q36627254-0D90CC88-C3A3-4A14-8007-1297A37D8A83Q36642502-A7644C82-6766-4487-9D04-5FE699350042Q36646936-D1062F4C-8611-471F-837D-EFF5020BC2E3Q36757173-A8723737-102D-4F31-A91F-153004B4E9BBQ36788485-078EF1BE-D8F1-494E-B479-D52874AC1981Q36791878-640D1817-388A-4925-96D2-A574DE6EF6C5Q36797398-BF02CC2F-D245-4DCF-B2EB-60167B0C48BAQ36918144-DD142B11-156E-4ADB-870C-0BDEC6286A4CQ36944022-69996C70-55EF-461F-9E92-E2A588684433Q37052752-D4BBF371-958E-49A6-9AC2-F3D8FEA59A53Q37089778-F54C4587-CAF7-4362-B16C-0F8984B6AD30
P2860
Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@ast
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@en
type
label
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@ast
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@en
prefLabel
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@ast
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@en
P2093
P2860
P356
P1476
Monoclonal antibody against ep ...... ting receptor phosphorylation.
@en
P2093
C L MacLeod
J Mendelsohn
P2860
P304
P356
10.1073/PNAS.83.11.3825
P407
P577
1986-06-01T00:00:00Z